The role of biotechnologically engineered vaccines and diagnostics in pseudorabies (Aujeszky's disease) eradication strategies

Veterinary Microbiology

Volumn 55, Issue 1-4, 1997, Pages 49-60

  Mengeling, W L ^a   Brockmeier, S L ^a   Lager, K M ^a   Vorwald, A C ^a  

^a NATIONAL ANIMAL DISEASE CENTER   (United States)

Author keywords

Biotechnology; Diagnosis; Disease eradication; Genetic engineering; Glycoproteins; Vaccines; Vectors

Indexed keywords

BIOTECHNOLOGY; CONFERENCE PAPER; GENETIC ENGINEERING; INFECTION PREVENTION; NONHUMAN; PSEUDORABIES; PSEUDORABIES HERPETOVIRUS; VACCINATION;

ANIMALS; BIOTECHNOLOGY; GENETIC ENGINEERING; GENETIC VECTORS; PSEUDORABIES; PSEUDORABIES VACCINES; SWINE; VACCINES, ATTENUATED; VACCINES, SYNTHETIC; VACCINIA VIRUS; VIRAL VACCINES;

HERPETOVIRUS; SUID HERPESVIRUS 1;

EID: 0030832568     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1135(96)01306-5     Document Type: Conference Paper

References (72)

1. Adam, M., Lepottier, M.F. and Eloit, M., 1994. Vaccination of pigs with replication-defective adenovirus vectored vaccines: the example of pseudorabies. Vet. Microbiol., 42: 205-215.
2. Ben-Porat, T., DeMarchi, J.M., Lomniczi, B. and Kaplan, A.S., 1986a. Role of glycoproteins of pseudorabies virus in eliciting neutralizing antibodies. Virology, 154: 325-334.
3. Ben-Porat, T., DeMarchi, J., Pendrys, J., Veach, R.A. and Kaplan, A.S., 1986b. Proteins specified by the short unique region of the genome of pseudorabies virus play a role in the release of virions from certain cells. J. Virol., 57: 191-196.
4. Brockmeier, S.L., Lager, K.M., Tartaglia, J., Riviere, M., Paoletti, E. and Mengeling, W.L., 1993. Vaccination of pigs against pseudorabies with highly attenuated vaccinia (NYVAC) recombinant viruses. Vet. Microbiol., 38: 41-58.
5. Christensen, L.S. and Lomniczi, B., 1993. High frequency intergenomic recombination of suid herpesvirus 1 (SHV-1, Aujeszky's disease virus). Arch. Virol., 132: 37-50.
6. Dangler, C.A., Deaver, R.E. and Kolodziej, C.M., 1994. Genetic recombination between two strains of Aujeszky's disease virus at reduced multiplicity of infection. J. Gen. Virol., 75: 295-299.
7. Dean, H.J. and Cheung, A.K., 1995. A deletion at the UL/IR junction reduces pseudorabies virus neurovirulence. J. Virol., 69: 1334-1338.
8. Dorner, F., 1995. An overview of vaccine vectors. In: eds. Basel and Karger, Non-Target Effects of Live Vaccines. Dev. Biol. Stand., 84: 23-32.
9. Eiras, A., Puentes, E., Seoane, R., Cancio, E., Nores, M.V. and Regueiro, B.J., 1992. Antigens involved in vaccination of swine against Aujeszky's disease (pseudorabies) virus. J. Vet. Med. B, 39: 526-536.
10. Eloit, M., Fargeaud, D., L'Haridon, R. and Toma, B., 1988. Identification of the pseudorabies virus glycoprotein gp5O as a major target of neutralizing antibodies. Arch. Virol., 99: 45-46.
11. Eloit, M., Fargeaud, D., Vannier, P. and Toma, B., 1989. Development of an ELISA to differentiate between animals either vaccinated with or infected by Aujeszky's disease virus. Vet. Rec., 124: 91-94.
12. Eloit, M., Bouzghaia, H. and Toma, B., 1990. Identification of antigenic sites on pseudorabies virus glycoprotein gp5O implicated in virus penetration of the host cell. J. Gen. Virol., 71: 2179-2183.
13. Eloit, M., Vannier, P., Hutet, E. and Fournier, A., 1992. Correlation between gI, gII, gIII, and gp5O antibodies and virus excretion in vaccinated pigs infected with pseudorabies virus. Arch. Virol., 123: 135-143.
14. Ganne, V., Eloit, M., Laval, A., Adam, M. and Trouve, G., 1993. High enhancement of the efficiency of a defective recombinant adenovirus expressing the pseudorabies virus glycoprotein gp50 gene formulated in oil adjuvants. In: European Society for Veterinary Virology, Proceedings of the International Symposium on Aujeszky's Disease Virus, 29-31 Aug. 1993, Budapest, Hungary, p. 23.
15. Hanssens, F.P., Nauwynck, H.J. and Pensaert, M.B., 1993. Involvement of membrane-bound viral glycoproteins in adhesion of pseudorabies virus-infected cells. J. Virol., 67: 4492-4496.
16. Heffner, S., Kovacs, F., Klupp, B.G. and Mettenleiter, T.C., 1993. Glycoprotein gp5O-negative pseudorabies virus: a novel approach toward a nonspreading live herpesvirus vaccine. J. Virol., 67: 1529-1537.
17. Iglesias, G., Molitor, T., Reed, D. and L'Italien, J., 1990. Antibodies to Aujeszky's disease virus in pigs immunized with purified virus glycoproteins. Vet. Microbiol., 24: 1-10.
18. Inumaru, S. and Yamada, S., 1991. Characterization of pseudorabies virus neutralization antigen glycoprotein gIII produced in insect cells by a baculovirus expression factor. Virus Res., 21: 123-139.
19. Ishii, H., Kobayashi, Y., Kuroki, M. and Kodama, Y., 1988. Protection of mice from lethal infection with Aujeszky's disease virus by immunization with purified gVI. J. Gen. Virol., 69: 1411-1414.
20. Jacobs, L., 1994. Glycoprotein E of pseudorabies virus and homologous proteins in other alphaherpesvirinae. Arch. Virol., 137: 209-228.
21. Karger, A. and Mettenleiter, T.C., 1993. Glycoproteins gIII and gp50 play dominant roles in the biphasic attachment of pseudorabies virus. Virology, 194: 654-664.
22. Kimman, T.G., Pol, J.M.A., de Wind, N., Oei-Lie, N., Berns, A.J.M. and Gielkens, A.L.J., 1992. Role of different genes in the virulence and pathogenesis of Aujeszky's disease virus. Vet. Microbiol., 33: 45-52.
23. Kit, S., 1990. Genetically engineered vaccines for control of Aujeszky's disease (pseudorabies). Vaccine, 8: 420-424.
24. Kit, S., Sheppard, M., Ichimura, H. and Kit, M., 1987. Second-generation pseudorabies virus vaccine with deletions in thymidine kinase and glycoprotein genes. Am. J. Vet. Res., 48: 780-793.
25. Kit, S., Kit, M., McConnel, S. and Lawhorn, B., 1993. Development of active immunity in passively protected newborn pigs with glycoprotein gIII-deleted ADV marker vaccine. In: European Society for Veterinary Virology, Proceedings of the International Symposium on Aujeszky's Disease Virus, 29-31 Aug. 1993, Budapest, Hungary, p. 22.
26. Kleiboeker, S.B., 1995. Identification and sequence analysis of the E1 genomic region of a porcine adenovirus. Virus Res., 36: 259-268.
27. Klupp, B.G., Baumeister, J., Visser, N. and Mettenleiter, T.C., 1993a. Identification and characterization of two novel glycoproteins in pseudorabies virus, gK and gL. In: European Society for Veterinary Virology, Proceedings of the International Symposium on Aujeszky's Disease Virus, 29-31 Aug. 1993, Budapest, Hungary, p. 13.
28. Klupp, B.G., Kern, H., Lomniczi, B. and Mettenleiter, T.C., 1993b. Pseudorabies virus avirulent strain Bartha contains attenuating point mutations in the UL21 gene. In: European Society for Veterinary Virology, Proceedings of the International Symposium on Aujeszky's Disease Virus, 29-31 Aug. 1993, Budapest, Hungary, p. 19.
29. Kopp, A. and Mettenleiter, T.C., 1993. Unidirectional complementation between the gB-homologous glycoproteins gII (PrV) and gI (BHV-1). In: European Society for Veterinary Virology, Proceedings of the International Symposium on Aujeszky's Disease Virus, 29-31 Aug. 1993, Budapest, Hungary, p. 15.
30. Kost, T.A., Jones, E.V., Smith, K.M., Reed, A.P., Brown, A.L. and Miller, T.J., 1989. Biological evaluation of glycoproteins mapping to two distinct mRNAs within the BamHI fragment 7 of pseudorabies virus: expressing of the coding regions by vaccinia virus. Virology, 171: 365-376.
31. Kritas, S.K., Pensaert, M.B. and Mettenleiter, T.C., 1994. Invasion and spread of single glycoprotein deleted mutants of Aujeszky's disease virus (ADV) in the trigeminal nervous pathway of pigs after intranasal inoculation. Vet. Microbiol., 40: 323-334.
32. Lomniczi, B., Watanabe, S., Ben-Porat, T. and Kaplan, A.S., 1984. Genetic basis of the neurovirulence of pseudorabies virus. J. Virol., 52: 198-205.
33. Lomniczi, B., Watanabe, S., Ben-Porat, T. and Kaplan, A.S., 1987. Genome location and identification of functions defective in the Bartha vaccine strain of pseudorabies virus. J. Virol., 61: 796-801.
34. Lomniczi, B., Kopp, A. and Mettenleiter, T.C., 1993. Altered virulence for pigs of a gII-deleted pseudorabies virus recombinant expressing the homologous glycoprotein gI of bovine herpesvirus 1. In: European Society for Veterinary Virology, Proceedings of the International Symposium on Aujeszky's Disease Virus, 29-31 Aug. 1993, Budapest, Hungary, p. 20.
35. Marchioli, C.C., Yancey, R.J., Petrovskis, E.A., Timmins, J.G. and Post, L.E., 1987a. Evaluation of pseudorabies virus glycoprotein gp5O as a vaccine for Aujeszky's disease in mice and swine: expression by vaccinia virus and Chinese hamster ovary cells. J. Virol., 61: 3977-3982.
36. Marchioli, C.C., Yancey, R.J., Wardley, R.C., Thomsen, D.R. and Post, L.E., 1987b. A vaccine strain of pseudorabies virus with deletions in the thymidine kinase and glycoprotein X genes. Am. J. Vet. Res., 48: 1577-1583.
37. Marchioli, C., Yancey, R.J., Timmins, J.G., Post, L.E., Young, B.R. and Povendo, D.A., 1988. Protection of mice and swine from pseudorabies virus-induced mortality by administration of pseudorabies virus-specific mouse monoclonal antibodies. Am. J. Vet. Res., 49: 860-864.
38. McGregor, S., Easterday, B.C., Kaplan, A.S. and Ben-Porat, T., 1985. Vaccination of swine with thymidine kinase-deficient mutants of pseudorabies virus. Am. J. Vet. Res., 46: 1494-1497.
39. Mellencamp, M.W., Pfeiffer, N.E., Suiter, B.T., Harness, J.R. and Beckenhauer, W.H., 1989. Identification of pseudorabies virus-exposed swine with a gI glycoprotein enzyme-linked immunosorbent assay. J. Clin. Microbiol., 27: 2208-2213.
40. Mengeling, W.L., 1991. Virus reactivation in pigs latently infected with a 20 thymidine kinase negative vaccine strain of pseudorabies virus. Arch. Virol., 120: 57-70.
41. Mengeling, W.L., Lager, K.M., Volz, D.M. and Brockmeier, S.L., 1992. Effect of various vaccination procedures on shedding, latency, and reactivation of attenuated and virulent pseudorabies virus in swine. Am. J. Vet. Res., 53: 2164-2173.
42. Mengeling, W.L., Brockmeier, S.L. and Lager, K.M., 1994a. Evaluation of a recombinant vaccinia virus containing pseudorabies (PR) virus glycoprotein genes gp50, gII, and gIII as a PR vaccine for pigs. Arch. Virol., 134: 259-269.
43. Mengeling, W.L., Brockmeier, S.L., Lager, K.M., Vorwald, A.C., Paoletti, E. and Vandeputte, J., 1994b. The potential for use of vaccinia-vectored vaccines in Aujeszky's disease eradication programs, In: Proceedings of the 13th Congress of the International Pig Veterinary Society, 26-30 June, 1994, Bangkok, Thailand, p. 47.
44. Mettenleiter, T.C., 1989. Glycoprotein gIII deletion mutants of pseudorabies virus are impaired in virus entry. Virology, 171: 623-625.
45. Mettenleiter, T.C., 1991. Molecular biology of pseudorabies (Aujeszky's disease) virus. Comp. Immun. Microbiol. Infect. Dis., 14: 151-163.
46. Mettenleiter, T.C., Lukacs, N. and Rziha, H.J., 1985. Pseudorabies virus avirulent strains fail to express a major glycoprotein. J. Virol., 56: 307-311.
47. Mettenleiter, T.C., Schreurs, C., Zuckermann, F. and Ben-Porat, T., 1987. Role of pseudorabies virus glycoprotein gI in virus release from infected cells. J. Virol., 61: 2764-2769.
48. Moormann, R.J.M., de Rover, T., Briaire, J., Peeters, B.P.H., Gielkens, A.L.J. and van Oirschot, J.T., 1990. Inactivation of the thymidine kinase gene of a gI deletion mutant of pseudorabies virus generates a safe but still highly immunogenic vaccine strain. J. Gen. Virol., 71: 1591-1595.
49. Mukamoto, M., Watanabe, I., Kobayashi, Y., Icatlo, F.C., Ishii, H. and Kodama, Y., 1991. Immunogenicity in Aujeszky's disease virus structural glycoprotein gVI (gp5O) in swine. Vet. Microbiol., 29: 109-121.
50. Nakamura, T., Ihara, T., Nagata, T., Ishihama, A. and Ueda, S., 1990. A complement-dependent neutralizing monoclonal antibody against glycoprotein II of pseudorabies virus. Vet. Microbiol., 24: 193-198.
51. Nakamura, T., Ihara, T., Nunoya, T., Kuwahara, H., Ishihama, A. and Ueda, S., 1993. Role of pseudorabies virus glycoprotein II in protection from lethal infection. Vet. Microbiol., 36: 83-90.
52. Pensaert, M., Gielkens, A.L.J., Lomniczi, B., Kimman, T.G., Vannier, P. and Eloit, M., 1992. Round table on control of Aujeszky's disease and vaccine development based on molecular biology. Vet. Microbiol., 33: 53-67.
53. Petrovskis, E.A., Timmins, J.G., Gierman, T.M. and Post, L.E., 1986. Deletions in vaccine strains of pseudorabies virus and their effect on synthesis of glycoprotein gp63. J. Virol., 60: 1166-1169.
54. Platt, K.B., 1984. The evaluation of a lectin-agarose based subunit vaccine and complementary diagnostic antigen for Aujeszky's disease (pseudorabies) in the pig. Vet. Microbiol., 9: 35-51.
55. Rauh, I. and Mettenleiter, T.C., 1991. Pseudorabies virus glycoproteins gII and gp5O are essential for virus penetration. J. Virol., 65: 5348-5356.
56. Reddy, P.S., Nagy, E. and Derbyshire, J.B., 1995. Sequence analysis of putative pVIII, E3 and fibre regions of porcine adenovirus type 3. Virus Res., 36: 97-106.
57. Riviere, M., Tartaglia, J., Perkus, M.E., Norton, E.K., Bongermino, C.M., Lacoste, F., Duret, C., Desmettre, P. and Paoletti, E., 1992. Protection of mice and swine from pseudorabies virus conferred by vaccinia virus-based recombinants. J. Virol., 66: 3424-3434.
58. Schmitt, B.J., Osorio, F.A., Stroup, W.W. and Gibbs, E.P.J., 1991. A comparison of differential diagnostic tests to detect antibodies to pseudorabies glycoproteins gX, gI, and gIII in naturally infected feral pigs. J. Vet. Diagn. Invest., 3: 344-345.
59. Swenson, S.L., McMillen, J. and Hill, H.T., 1993a. Evaluation of the safety and efficacy of a thymidine kinase, inverted repeat, gI, and gpX gene-deleted pseudorabies vaccine. J. Vet. Diagn. Invest., 5: 341-346.
60. Swenson, S.L., McMillen, J. and Hill, H.T., 1993b. Diagnostic compatibility of a thymidine kinase, inverted repeat, gI, and gpX modified live gene-deleted PRV vaccine with three differential ELISAs. J. Vet. Diagn. Invest., 5: 347-350.
61. Tartaglia, J., Perkus, M.E., Taylor, J., Norton, E.K., Audonnet, J.C., Cox, W.I., Davis, S.W., van der Hoeven, J., Meignier, B., Riviere, M., Languet, B. and Paoletti, E., 1992. NYVAC: A highly attenuated strain of vaccinia virus. Virology, 188: 217-232.
62. Thawley, D.G. and Morrison, R.B., 1988. Programs for elimination of pseudorabies virus from large herds of swine. J. Am. Vet. Med. Assoc., 193: 184-190.
63. Tuboly, T., Nagy, E. and Derbyshire, J.B., 1993. Potential viral vectors for the stimulation of mucosal antibody responses against enteric viral antigens in pigs. Res. Vet. Sci., 54: 345-350.
64. Vandeputte, J., Chappuis, G., Fargeaud, D., Precausta, P., Guillemin, F., Brun, A., Desmettre, Ph. and Stellmann, C., 1990. Vaccination against Pseudorabies with glycoprotein gI+ or glycoprotein gI -vaccine. Am. J. Vet. Res., 51: 1100-1106.
65. van der Leek, M.L., Feller, J.A., Sorensen, G., Isaacson, W., Adams, C.L., Borde, D.J., Pfeiffer, N., Tran, R., Moyer, R.W. and Gibbs, E.P.J., 1994. Evaluation of swinepox virus as a vaccine vector in pigs using an Aujeszky's disease (pseudorabies) virus gene insert coding for glycoproteins gp50 and gp63. Vet. Rec., 134: 13-18.
66. van Oirschot, J.T., Houwers, D.J., Rziha, H.J. and Moonen, P.J.L.M., 1988. Development of an ELISA for detection of antibodies to glycoprotein I of Aujeszky's disease virus: a method for the serological differentiation between infected and vaccinated pigs. J. Virol. Methods, 22: 191-206.
67. van Oirschot, J.T., Gielkens, A.L.J., Moormann, R.J.M. and Berns, A.J.M., 1990. Marker vaccines, virus protein-specific antibody assays and the control of Aujeszky's disease. Vet. Microbiol., 23: 85-101.
68. Wittmann, G. and Rziha, H.J., 1989. Aujeszky's disease (pseudorabies) in pigs. In: ed. G. Wittmann, Herpesvirus Diseases of Cattle, Horses, and Pigs, Kluwer Academic Publishers, Boston, pp. 230-325.
69. Xuan, X., Nakamura, T., Ihara, T., Sato, I., Tuchiya, K., Nosetto, E., Ishihama, A. and Ueda, S., 1995. Characterization of pseudorabies virus glycoprotein gII expressed by recombinant baculovirus. Virus Res., 36: 151-161.
70. Zsak, L., Zuckermann, F. and Ben-Porat, T., 1993. The role of gI and gIII nonessential glycoproteins in the virulence of Aujeszky's disease virus (ADV). In: European Society for Veterinary Virology, Proceedings of the International Symposium on Aujeszky's Disease Virus, 29-31 Aug. 1993, Budapest, Hungary, p. 16.
71. Zuckermann, F.A., Mettenleiter, T.C., Schreurs, C., Sugg, N. and Ben-Porat, T., 1988. Complex between glycoproteins gI and gp63 of pseudorabies virus: its effect on virus replication. J. Virol., 62: 4622-4626.
72. Zuckermann, F., Zsak, L., Reilly, L., Sugg, N. and Ben-Porat, T., 1989. Early interactions of pseudorabies virus with host cells: functions of glycoprotein gIII. J. Virol., 63: 3323-3329.